Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

• Eduardo Rodríguez-Arbolí,
• Megan Othus,
• Corentin Orvain,
• Lucas C. Zarling,
• Brenda M. Sandmaier,
• Filippo Milano,
• Gary Schoch,
• Chris Davis,
• H. Joachim Deeg,
• Frederick R. Appelbaum,
• Rainer Storb,
• Roland B. Walter

Affiliations

Eduardo Rodríguez-Arbolí

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville

Megan Othus

Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA

Corentin Orvain

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Lucas C. Zarling

Department of Medicine, Residency Program, University of Washington, Seattle, WA

Brenda M. Sandmaier

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA

Filippo Milano

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA

Gary Schoch

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Chris Davis

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

H. Joachim Deeg

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA

Frederick R. Appelbaum

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA

Rainer Storb

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA

Roland B. Walter

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA